Heidelberg Pharma AG (ETR:HPHA)

Revenue by Segment

Financials in millions EUR. Fiscal year is December - November.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Nov 30, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021	Nov 30, 2020	Nov 30, 2019	Nov 30, 2018	Nov 30, 2017	Nov 30, 2016
Biotechnology (Startups)	1.46M	6.85M	9.86M	18.51M	2.03M
Total	1.46M	6.85M	9.86M	18.51M	2.03M

Revenue by Geography

Financials in millions EUR. Fiscal year is December - November.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Nov 30, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021	Nov 30, 2020	Nov 30, 2019	Nov 30, 2018	Nov 30, 2017	Nov 30, 2016
Germany	5.00K	34.00K	60.00K	549.00K	477.00K
USA	285.00K	2.14M	4.67M	8.98M	1.12M
China	1.17M	4.67M	4.74M	8.20M	-
Switzerland	-	-	145.00K	52.00K	38.00K
Rest of The World (Excluding China)	-	-	242.00K	727.00K	113.00K
Total	1.46M	6.85M	9.86M	18.51M	1.75M

Data Source: S&P Global Market Intelligence Last updated: May 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 26, 2026

Data Sources Report a data error